Accelerate gene therapy downstream process development using scalable pre-packed chromatography columns

Cell & Gene Therapy Insights 2024; 10(7), 981

DOI: 10.18609/cgti.2024.111

Published: 4 September
FastFacts
Tim Schroeder


Watch the video or view the poster to learn more about:

  • reducing AAV purification times through the implementation of a DoE approach to optimize your process;
  • facilitation of scale up using pre-packed columns to ensure reproducibility in your workflow;
  • advancing chromatography strategies to enable rapid response to evolving gene therapy demands and regulatory challenge

Tim Schroeder is the Director of Product Management at Repligen, Waltham, MA, USA, responsible for the OPUS® portfolio of pre-packed chromatography columns for process development. Before this, Tim was Head of Production at Atoll GmbH and was involved in developing and producing chromatography columns. He graduated with a Degree in Dipl.-Ing. from FH Aachen—University of Applied Sciences Aachen, Germany, majoring in Biotechnology.